Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled, aerosolized Tobramycin (TOBI) b.i.d. in patients with ventilator-associated pneumonia (VAP)

Trial Profile

Prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled, aerosolized Tobramycin (TOBI) b.i.d. in patients with ventilator-associated pneumonia (VAP)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Nosocomial pneumonia
  • Focus Therapeutic Use
  • Acronyms iTO-VAP
  • Most Recent Events

    • 11 Sep 2019 Status changed from recruiting to completed.
    • 05 May 2019 Planned End Date changed from 9 Dec 2014 to 9 Feb 2020.
    • 27 Dec 2014 Planned number of patients changed from 90 to 28 as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top